Piper Sandler reiterates Federal Realty stock rating on earnings outlook By Investing.com
Piper Sandler reiterated an Overweight rating and a $127.00 price target on Federal Realty Investment Trust (NYSE:FRT) citing limited supply, consumer resilience, and retailer demand as supporting factors for the company's earnings outlook. The stock is trading near its 52-week high, with a strong year-to-date return, although it's considered overvalued by InvestingPro. Federal Realty recently reported Q1 2026 earnings that significantly surpassed analyst expectations, showcasing robust financial performance and strengthening investor confidence.
Applied Materials stock hits all-time high at 448.62 USD By Investing.com
Applied Materials Inc. (AMAT) stock has reached an all-time high of $448.62, showcasing robust investor confidence and strong market performance, with a 176.59% increase over the past year. Despite its current valuation suggesting it may be overvalued based on a P/E ratio of 42.07, analysts have revised earnings upwards, and its strong performance is bolstered by strategic collaborations in advanced chip packaging technologies for AI systems. The company recently reported strong quarterly results, surpassing revenue and EPS estimates, leading to increased price targets from several analyst firms.
Qualcomm stock hits all-time high at $247.91
Qualcomm (QCOM) stock has hit an all-time high of $247.91, marking a 68% total return over the past year due to strong market positioning and innovative advancements. Despite this, InvestingPro analysis suggests the shares may be overvalued relative to Fair Value estimates, trading at a P/E ratio of 26.85 with a market capitalization of $258 billion. The company has recently received analyst upgrades, increased price targets, and announced a new $20 billion share buyback program.
BridgeBio Pharma (BBIO) Downgraded by Raymond James Amid Competitive Pressures
BridgeBio Pharma (BBIO) was downgraded by Raymond James from Outperform to Market Perform due to concerns over future competitive pressures. The downgrade, which also removed an $89 price target, stems from the impending loss of exclusivity for Pfizer's Vyndamax, a competitor to BridgeBio's Attruby, which could lead to increased generic competition. This situation is expected to hinder new patient starts for Attruby beyond 2031, impacting BridgeBio's market share and revenue growth potential.
Northwest Bank Hires Former Wells Fargo Executive Chad Ballard as CIO
Northwest Bank has appointed Chad Ballard, a veteran banking technology executive and former Wells Fargo CIO, as its new Chief Information Officer. Ballard will lead the bank's IT strategy, focusing on modernization, customer experience, and scalability, with an emphasis on AI deployment and digital transformation. This hire reflects the increasing importance of technology leadership and AI integration among regional banks to compete effectively and meet evolving customer and regulatory demands.
RBC Capital raises Albemarle stock price target on growth outlook By Investing.com
RBC Capital has increased its price target for Albemarle Corp. (NYSE: ALB) shares to $257 from $253, maintaining an Outperform rating due to a positive growth outlook. The firm adjusted its EBITDA estimates upward for Q2 2026, full-year 2026, and 2027, driven by expected volume growth, cost reductions, and higher lithium prices. This adjustment follows a recent modeling session and the company's strong Q1 2026 earnings report, where both EPS and revenue surpassed Wall Street expectations.
Rising Treasury yields: Recalibration, not rupture
Rising Treasury yields reflect a market recalibration driven by stronger growth expectations and an increased term premium, rather than a fundamental rupture in confidence in US debt. Inflation expectations remain contained despite higher energy prices, suggesting investors believe inflation can be managed. Broad market indicators like Treasury auctions, the US dollar, credit spreads, and stock performance suggest the market has absorbed the higher rates without widespread disruption.
17 New 4-Star Stocks This Week
Morningstar identified 17 US-listed stocks that became newly undervalued this week, earning a 4-star rating, with 8 others reaching 5-star status. The article highlights five prominent companies among the new 4-star stocks by market capitalization: Nvidia, Blackstone, Lowe's, Automatic Data Processing, and Kohlberg Kravis Roberts. These stocks are considered undervalued based on Morningstar's fair value estimates, stock prices, and uncertainty ratings, despite varying recent performance.
Western Digital (WDC) Shares Rise as Evercore Increases Price Ta
Western Digital (WDC) shares rose 3% in premarket trading after Evercore raised its price target from $550 to $575, citing the company's undervaluation and the critical role of hard disk drives (HDDs) in AI infrastructure. Evercore anticipates sustained sales growth over 20% and EPS growth over 30% for WDC. Despite this positive outlook, the stock's P/E ratio of 29.98x suggests it may be significantly overvalued, and insider selling totaling $24.6 million in the last three months raises potential concerns for investors.
Sandisk stock hits all-time high of 1600.64 USD By Investing.com
SanDisk Corporation's stock reached an all-time high of 1600.64 USD, pushing its market capitalization to $234 billion, reflecting a 4045.21% gain over the past year. Analysts from Cantor Fitzgerald, Bernstein SocGen Group, and Jefferies have raised price targets, while S&P Global Ratings upgraded the company's rating to BB+ due to debt repayment and substantial cash balance. Despite the rally, InvestingPro suggests the stock may be overvalued relative to its Fair Value.













